Synonyms:tetracaine, 94-24-6, Amethocaine, 2-(Dimethylamino)ethyl 4-(butylamino)benzoate, Pontocaine, Dicaine, Laudocaine, Metraspray, Tetrakain, Anetain, Contralgin, Meethobalm, Mucaesthin, Tetracaina, Tetracainum, Uromucaesthin, Fissucain, Intercain, Medicaine, Niphanoid, Rexocaine, Dicain, Dikain, Medihaler-Tetracaine, 2-(Dimethylamino)ethyl p-(butylamino)benzoate, p-Butylaminobenzoyl-2-dimethylaminoethanol, Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester, Diaethylaminoaethanol ester der p-butylaminobenzoesaeure, 4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester, Dimethylaminoethyl p-butyl-aminobenzoate, CHEBI:9468, p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester, MFCD00053787, CHEMBL698, BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER, 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove, Tetracaine Base, 0619F35CGV, Butylocaine, Tetrakain [Czech], Tetracainum [INN-Latin], Tetracaina [INN-Spanish], p-(butylamino)benzoic acid beta-(dimethylamino)ethyl ester, Amethocaine (TN), Tetracaine (USP/INN), NCGC00016049-02, CAS-136-47-0, EINECS 202-316-6, BRN 2216051, Landocaine, Tetracain, Tetracaine [USP:INN:BAN], UNII-0619F35CGV, Amethocaine HCl, 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech], Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German], TE4, Spectrum_001032, Pantocaine (Salt/Mix), TETRACAINE [INN], 100311-22-6, Prestwick0_000571, Prestwick1_000571, Prestwick2_000571, Prestwick3_000571, Spectrum2_001328, Spectrum3_000562, Spectrum4_000351, Spectrum5_001072, Lopac-T-7508, TETRACAINE [VANDF], Epitope ID:174843, TETRACAINE [MART.], TETRACAINE [USP-RS], TETRACAINE [WHO-DD], Lopac0_001211, SCHEMBL34714, BSPBio_000382, BSPBio_001944, KBioGR_000781, KBioSS_001512, 4-14-00-01172 (Beilstein Handbook Reference), DivK1c_000607, SPBio_001455, SPBio_002601, BPBio1_000422, TETRACAINE [GREEN BOOK], Tetracaine, >=98% (TLC), DTXSID1043883, TETRACAINE [ORANGE BOOK], KBio1_000607, KBio2_001512, KBio2_004080, KBio2_006648, KBio3_001444, TETRACAINE [EP MONOGRAPH], NINDS_000607, SYNERA COMPONENT TETRACAINE, BCPP000048, TETRACAINE [USP MONOGRAPH], ACT04765, BCP04777, HY-A0079, BDBM50017659, STL483844, TETRACAINE COMPONENT OF SYNERA, AKOS015889234, AC-3480, CCG-205285, DB09085, SDCCGSBI-0051178.P005, IDI1_000607, NCGC00016049-01, NCGC00016049-03, NCGC00016049-04, NCGC00016049-14, NCGC00162367-01, AS-81743, SY066710, BCP0726000001, SBI-0051178.P004, AB00053549, FT-0656378, T2789, Tetracaine, meets USP testing specifications, .beta.-Dimethylaminoethyl p-butylaminobenzoate, 2-(Dimethylamino)ethyl4-(n-butylamino)benzoate, C07526, D00551, 2-(Dimethylamino)ethyl 4-(butylamino)benzoate #, AB00053549-11, AB00053549_12, AB00053549_13, EN300-6748839, Q419608, Q-201805, BRD-K45071273-003-05-8, BRD-K45071273-003-15-7, Tetracaine, United States Pharmacopeia (USP) Reference Standard, BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE
Pubchem:PUBCHEM:5411
Id:b2cf6909-c18d-5713-9724-b44de9d7895c
Description:nan
